LB Pharmaceuticals Inc LBRX
Updated: 9 Aug 2026
No signal published yet
We already track LB Pharmaceuticals and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow LB Pharmaceuticals Inc? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow LB Pharmaceuticals free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On July 29, 2026, LB Pharmaceuticals announced a $150 million private placement offering of common stock and pre-funded warrants. The capital raised will support the expansion of clinical development for its lead asset LB-102 into additional indications, as well as general corporate needs.
What Firelda Watch includes for LB Pharmaceuticals Inc
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow LB Pharmaceuticals Inc? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow LB Pharmaceuticals free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more